| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A current review of COVID-19 for the cardiovascular specialist
|
Lang, Joshua P.
|
|
|
226 |
C |
p. 29-44
|
artikel
|
| 2 |
Acute myocardial infarction under-diagnosis and mortality in a Tanzanian emergency department: A prospective observational study
|
Hertz, Julian T.
|
|
|
226 |
C |
p. 214-221
|
artikel
|
| 3 |
A multicenter trial of a shared DECision Support Intervention for Patients offered implantable Cardioverter-DEfibrillators: DECIDE-ICD rationale, design, Medicare changes, and pilot data
|
Wallace, Bryan C.
|
|
|
226 |
C |
p. 161-173
|
artikel
|
| 4 |
Anticipating and curtailing the cardiometabolic toxicity of social isolation and emotional stress in the time of COVID-19
|
Oren, Ohad
|
|
|
226 |
C |
p. 1-3
|
artikel
|
| 5 |
Back to the future—Are we ready for a randomized trial of surgical versus percutaneous revascularization in cardiogenic shock?
|
Katz, Jason N.
|
|
|
226 |
C |
p. 264-266
|
artikel
|
| 6 |
Cardiovascular comorbidities, cardiac injury, and prognosis of COVID-19 in New York City
|
Kuno, Toshiki
|
|
|
226 |
C |
p. 24-25
|
artikel
|
| 7 |
Cardiovascular implications of idiopathic pulmonary fibrosis: A way forward together?
|
Mosher, Christopher L.
|
|
|
226 |
C |
p. 69-74
|
artikel
|
| 8 |
Childhood cancer survivors: The integral role of the cardiologist and cardiovascular imaging
|
Bottinor, Wendy J
|
|
|
226 |
C |
p. 127-139
|
artikel
|
| 9 |
Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial
|
Lopes, Renato D.
|
|
|
226 |
C |
p. 49-59
|
artikel
|
| 10 |
Coronary artery bypass grafting versus percutaneous coronary intervention for myocardial infarction complicated by cardiogenic shock
|
Smilowitz, Nathaniel R.
|
|
|
226 |
C |
p. 255-263
|
artikel
|
| 11 |
Corrigendum to “Impact of creatinine clearance on clinical outcomes in elderly atrial fibrillation patients receiving apixaban: J-ELD AF Registry subanalysis” Am Heart J (2020)
|
Akao, Masaharu
|
|
|
226 |
C |
p. 270
|
artikel
|
| 12 |
COVID-19 and the cardiovascular system: A review of current data, summary of best practices, outline of controversies, and illustrative case reports
|
Prasad, Anand
|
|
|
226 |
C |
p. 174-187
|
artikel
|
| 13 |
Decrease in acute coronary syndrome presentations during the COVID-19 pandemic in upstate New York
|
Braiteh, Nabil
|
|
|
226 |
C |
p. 147-151
|
artikel
|
| 14 |
Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II)
|
Jackson II, Larry R.
|
|
|
226 |
C |
p. 85-93
|
artikel
|
| 15 |
Discrepancy in recognition of symptom burden among patients with atrial fibrillation
|
Katsumata, Yoshinori
|
|
|
226 |
C |
p. 240-249
|
artikel
|
| 16 |
Does central venous pressure really affect the risk of diuretic-associated acute kidney injury after cardiac surgery?
|
Cheng, Yi
|
|
|
226 |
C |
p. 253-254
|
artikel
|
| 17 |
Does really central venous pressure affect the risk of diuretic-associated acute kidney injury after cardiac surgery?
|
McCoy, Ian
|
|
|
226 |
C |
p. 252
|
artikel
|
| 18 |
Editorial Board
|
|
|
|
226 |
C |
p. v
|
artikel
|
| 19 |
Extending physicians’ reach in grasping AF symptoms
|
Mirwais, Maiwand
|
|
|
226 |
C |
p. 250-251
|
artikel
|
| 20 |
High-intensity endurance training is associated with left atrial fibrosis
|
Peritz, David C.
|
|
|
226 |
C |
p. 206-213
|
artikel
|
| 21 |
Impact of COVID-19 epidemic on coronary care unit accesses for acute coronary syndrome in Veneto region, Italy
|
Folino, Antonio Franco
|
|
|
226 |
C |
p. 26-28
|
artikel
|
| 22 |
Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: Insights from a British cardiac center
|
Abdelaziz, Hesham K.
|
|
|
226 |
C |
p. 45-48
|
artikel
|
| 23 |
Impact of electrical cardioversion on quality of life for patients with symptomatic persistent atrial fibrillation: Is there a treatment expectation effect?
|
Ha, Andrew C.T.
|
|
|
226 |
C |
p. 152-160
|
artikel
|
| 24 |
Impact of salt substitute and stepwise reduction of salt supply on blood pressure in residents in senior residential facilities: Design and rationale of the DECIDE-Salt trial
|
Jin, Aoming
|
|
|
226 |
C |
p. 198-205
|
artikel
|
| 25 |
Information for Readers
|
|
|
|
226 |
C |
p. vi
|
artikel
|
| 26 |
Levels of evidence supporting drug, device, and other recommendations in the American Heart Association/American College of Cardiology guidelines
|
Fanaroff, Alexander C.
|
|
|
226 |
C |
p. 4-12
|
artikel
|
| 27 |
Optimal treatment of underlying conditions improves rhythm control outcome in atrial fibrillation – Data from RACE 3
|
Nguyen, Bao-Oanh
|
|
|
226 |
C |
p. 235-239
|
artikel
|
| 28 |
Outcomes and cost among Medicare beneficiaries hospitalized for heart failure assigned to accountable care organizations
|
Luo, Nancy
|
|
|
226 |
C |
p. 13-23
|
artikel
|
| 29 |
Overcoming underpowering: Trial simulations and a global rank end point to optimize clinical trials in children with heart disease
|
Hill, Kevin D.
|
|
|
226 |
C |
p. 188-197
|
artikel
|
| 30 |
Population-level surveillance of congenital heart defects among adolescents and adults in Colorado: Implications of record linkage
|
Crume, Tessa L.
|
|
|
226 |
C |
p. 75-84
|
artikel
|
| 31 |
Predictors of Fabry disease in patients with hypertrophic cardiomyopathy: How to guide the diagnostic strategy?
|
Azevedo, Olga
|
|
|
226 |
C |
p. 114-126
|
artikel
|
| 32 |
Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease
|
Gommans, D. H. Frank
|
|
|
226 |
C |
p. 60-68
|
artikel
|
| 33 |
Smartphone 12-lead ECG—Exciting but must be handled with care
|
Lindow, Thomas
|
|
|
226 |
C |
p. 267-268
|
artikel
|
| 34 |
Smartphone 12-lead ECG—Exciting but must be handled with care
|
Muhlestein, Joseph Brent
|
|
|
226 |
C |
p. 269
|
artikel
|
| 35 |
Table of Contents
|
|
|
|
226 |
C |
p. i-iv
|
artikel
|
| 36 |
The RICH LIFE Project: A cluster randomized pragmatic trial comparing the effectiveness of health system only vs. health system Plus a collaborative/stepped care intervention to reduce hypertension disparities
|
Cooper, Lisa A.
|
|
|
226 |
C |
p. 94-113
|
artikel
|
| 37 |
The Second Strategic Reperfusion Early After Myocardial Infarction (STREAM-2) study optimizing pharmacoinvasive reperfusion strategy in older ST-elevation myocardial infarction patients
|
Armstrong, Paul W.
|
|
|
226 |
C |
p. 140-146
|
artikel
|
| 38 |
Transcatheter InterAtrial Shunt Device for the treatment of heart failure: Rationale and design of the pivotal randomized trial to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure II (REDUCE LAP-HF II)
|
Berry, Natalia
|
|
|
226 |
C |
p. 222-231
|
artikel
|
| 39 |
Use and outcomes of wearable cardioverter-defibrillators in a large integrated academic health system
|
Kahn, Peter A.
|
|
|
226 |
C |
p. 232-234
|
artikel
|
Tijdschrift beschrijving